Skip to search.
 All Ordinaries Up 0.52%

More On PRR.AX

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Prima Biomed Ltd (PRR.AX)

-ASX
0.04 Down 0.00(2.70%) 16:10
Prev Close:0.04
Open:0.04
Bid:0.04
Ask:0.04
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:0.04 - 0.04
52wk Range:0.03 - 0.06
Volume:2,175,500
Avg Vol (3m):896,705
Market Cap:74.63M
P/E (ttm):N/A
EPS (ttm):-0.03
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in AUD.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):43.22
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-17) :-0.01
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):-1.23

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Prima BioMed Ltd. engages in the research, development, and commercialization of medical biotechnology products in Australia. The company develops immunotherapeutic products for the treatment of various types of cancer. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback